<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="2003 and 2012 respectively. The genome of SARS-CoV-2 originated in" exact="China" post="and has pp1ab, pp1a polyproteins, and codes for protein"/>
 <result pre="SARS-CoV-2 has not been published yet but media outlets from" exact="China" post="have alleged that these drugs can help reduce disease"/>
 <result pre="&amp;gt; 100 μM. There is a RCT in phase III in" exact="China" post="(registration number NCT04252274) for the treatment of COVID-19 with"/>
 <result pre="for every 12 h. It is an available treatment in" exact="Japan" post="but not in the USA for influenza infection [35–39]."/>
 <result pre="Live attenuated virus Deoptimized live attenuated vaccines Codagenix/Serum Institute of" exact="India" post="Pre-clinical Zika, Influenza, Dengue etc., Non-replicating viral vector ChAdOx1"/>
 <result pre="Cansino Biologics vaccines are in phase 2 clinical trials in" exact="China" post="and are using adenovirus type 5 as a replication"/>
 <result pre="adenovirus type 5 as a replication vector. The University of" exact="Hong Kong" post="is also developing a vaccine for COVID-19. It is"/>
 <result pre="(peptide), AJ Vaccines (S protein), Generex/EpiVax (Ii-Key peptide), EpiVax/Univ. of" exact="Georgia" post="(S protein), Sanofi Pasteur (S protein by baculovirus), Heat"/>
 <result pre="(LNP-encapsulated mRNA cocktail encoding VLP and LNP-encapsulated mRNA encoding RBD)," exact="China" post="CDC/Tongji University/Stermina/Arcturus/Duke-NUS/BioNTech/Fosun Pharma/Pfizer (mRNA), and Imperial College London (SaRNA)"/>
 <result pre="associated with a new coronavirus of probable bat originNature202057927027332015507 50.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab:" exact="China" post="Novel Coronavirus Investigating and Research TeamA novel coronavirus from"/>
</results>
